Pharmacotherapy in posttraumatic stress disorder: Historical and clinical considerations and future directions

J. R. Davidson, Charles Nemeroff

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Posttraumatic stress disorder (PTSD) has long been recognized as responsive to drug and somatic treatments. Clinical characteristics and patterns of treatment response were well described in the 1940s. Recent studies indicate that tricyclic antidepressants and monoamine oxidase inhibitors (MAOIs) have specific ameliorative effects on PTSD symptoms, but further work is needed in this regard. Goals of drug therapy are provided and future directions suggested.

Original languageEnglish
Pages (from-to)422-425
Number of pages4
JournalPsychopharmacology Bulletin
Volume25
Issue number3
StatePublished - Dec 1 1989
Externally publishedYes

Fingerprint

Post-Traumatic Stress Disorders
Drug Therapy
Monoamine Oxidase Inhibitors
Tricyclic Antidepressive Agents
Therapeutics
Pharmaceutical Preparations
Direction compound

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Pharmacology

Cite this

Pharmacotherapy in posttraumatic stress disorder : Historical and clinical considerations and future directions. / Davidson, J. R.; Nemeroff, Charles.

In: Psychopharmacology Bulletin, Vol. 25, No. 3, 01.12.1989, p. 422-425.

Research output: Contribution to journalArticle

@article{6af40813edf2418bbd3f41644fa2cb48,
title = "Pharmacotherapy in posttraumatic stress disorder: Historical and clinical considerations and future directions",
abstract = "Posttraumatic stress disorder (PTSD) has long been recognized as responsive to drug and somatic treatments. Clinical characteristics and patterns of treatment response were well described in the 1940s. Recent studies indicate that tricyclic antidepressants and monoamine oxidase inhibitors (MAOIs) have specific ameliorative effects on PTSD symptoms, but further work is needed in this regard. Goals of drug therapy are provided and future directions suggested.",
author = "Davidson, {J. R.} and Charles Nemeroff",
year = "1989",
month = "12",
day = "1",
language = "English",
volume = "25",
pages = "422--425",
journal = "Psychopharmacology Bulletin",
issn = "0048-5764",
publisher = "MedWorks Media LLC",
number = "3",

}

TY - JOUR

T1 - Pharmacotherapy in posttraumatic stress disorder

T2 - Historical and clinical considerations and future directions

AU - Davidson, J. R.

AU - Nemeroff, Charles

PY - 1989/12/1

Y1 - 1989/12/1

N2 - Posttraumatic stress disorder (PTSD) has long been recognized as responsive to drug and somatic treatments. Clinical characteristics and patterns of treatment response were well described in the 1940s. Recent studies indicate that tricyclic antidepressants and monoamine oxidase inhibitors (MAOIs) have specific ameliorative effects on PTSD symptoms, but further work is needed in this regard. Goals of drug therapy are provided and future directions suggested.

AB - Posttraumatic stress disorder (PTSD) has long been recognized as responsive to drug and somatic treatments. Clinical characteristics and patterns of treatment response were well described in the 1940s. Recent studies indicate that tricyclic antidepressants and monoamine oxidase inhibitors (MAOIs) have specific ameliorative effects on PTSD symptoms, but further work is needed in this regard. Goals of drug therapy are provided and future directions suggested.

UR - http://www.scopus.com/inward/record.url?scp=0024806517&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024806517&partnerID=8YFLogxK

M3 - Article

C2 - 2697012

AN - SCOPUS:0024806517

VL - 25

SP - 422

EP - 425

JO - Psychopharmacology Bulletin

JF - Psychopharmacology Bulletin

SN - 0048-5764

IS - 3

ER -